Tara A. Schwetz | |
---|---|
Deputy Director for Program Coordination, Planning, and Strategic Initiatives of the National Institutes of Health | |
Assumed office October 2023 | |
Principal Deputy Director of the National Institutes of Health | |
Acting | |
In office December 2021 –November 2023 | |
Preceded by | Lawrence A. Tabak |
Succeeded by | Lawrence A. Tabak |
Director of the National Institute of Nursing Research | |
Acting | |
In office January 2020 –September 2020 | |
Preceded by | Lawrence A. Tabak (acting) |
Succeeded by | Shannon Zenk |
Associate Deputy Director of the National Institutes of Health | |
In office January 2019 –November 2021 | |
Preceded by | Courtney F. Aklin (Acting) |
Personal details | |
Born | Lakeland,Florida,U.S. | May 4,1983
Spouse | Brian Schwetz |
Education | Florida State University (BS) University of South Florida (PhD) |
Tara A. Schwetz (born Tara Ashley Munn;May 4,1983) is an American biophysicist and government administrator who serves as a deputy director of the National Institutes of Health. She previously served as Acting Principal Deputy Director. [1] [2]
Prior to her appointment as Acting Principal Deputy Director,she served as the Associate Deputy Director,NIH—a role she has held began in January 2019. [3]
She joined the NIH in 2012 as an American Association for the Advancement of Science (AAAS) Science and Technology Policy Fellow and has held a number of positions during her time at the agency.
A native of Lakeland,Florida,Schwetz is a first-generation college graduate. Schwetz received a Bachelor of Science in Biochemistry with honors from Florida State University in 2005 (Honors Thesis:Non-metal activation of iron-dependent regulator protein in mycobacterium tuberculosis). She then went on to earn a Doctor of Philosophy in Medical Sciences,Biophysics from the University of South Florida in 2009 (Dissertation:Glycosylation Modulates Cardiac Excitability by Altering Voltage-Gated Potassium Currents [4] ). Schwetz was a postdoctoral researcher in the lab of David W. Piston at Vanderbilt University from 2009 to 2012. [5]
Throughout her nearly decade-long career at the NIH,Schwetz has held multiple positions,both within the Office of the Director and across several Institutes.
During her tenure as the Associate Deputy Director of NIH,Schwetz served as the Acting Director and Acting Deputy Director of the National Institute of Nursing Research (NINR). [6]
Her former roles include Chief of the Strategic Planning and Evaluation Branch at the National Institute of Allergy and Infectious Diseases,where she led several efforts,including an evaluation of the Centers of Excellence for Influenza Research and Surveillance [7] to facilitate evidence-based decision-making and development of the NIAID Strategic Plan for Tuberculosis Research. [8] [9] Schwetz also served as the Senior Advisor to the Principal Deputy Director of NIH,the NIH Environmental influences on Child Health Outcomes (ECHO) [10] Interim Associate Program Director, [11] and as a Health Science Policy Analyst at the National Institute of Neurological Disorders and Stroke. Schwetz started her career at NIH as an AAAS Science and Technology Policy Fellow at NINR.
Schwetz has led or co-led a number of high-profile,agency-wide efforts,including two Rapid Acceleration of Diagnostics (RADx) [12] programs (RADx Underserved Populations, [13] RADx Radical [14] ) [15] [16] to speed innovation in the development,commercialization,and implementation of technologies for COVID-19 testing,and the Implementing a Maternal health and Pregnancy Outcomes Vision for Everyone (IMPROVE) [17] [18] initiative. She also spearheaded several strategic planning efforts,such as the first NIH-Wide Strategic Plan and the NIH-Wide COVID-19 Strategic Plan; [19] [20] [21] and played a significant role in the development of the National Pain Strategy. [22] [23] [24]
For much of 2021,Schwetz served on detail to the White House Office of Science and Technology Policy as the Assistant Director for Biomedical Science Initiatives. [25] In this role,she led development and planning efforts to stand up the proposed Advanced Research Projects Agency for Health (ARPA-H). [26] [27] [28] [29] The Biden Administration proposed ARPA-H in the fiscal year 2022 President’s budget request [30] to tackle some of the biggest health challenges faced by all Americans by driving medical innovation more rapidly.
Schwetz is the recipient of numerous NIH awards,including the NIH Ruth Kirschstein National Research Service Award. In addition,she received awards from the American Cancer Society and American Heart Association. She is also the first female recipient of the USF Genshaft Family Doctoral Fellowship. [31]
The National Institutes of Health,commonly referred to as NIH,is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda,Maryland,and other nearby suburbs of the Washington metropolitan area,with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.
The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH),an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand,treat,and prevent infectious,immunologic,and allergic diseases.
The National Institute of Nursing Research (NINR),as part of the U.S. National Institutes of Health,supports clinical and basic research to establish a scientific basis for the nursing care of individuals across the life span—from management of patients during illness and recovery,to the reduction of risks for disease and disability,and the promotion of healthy lifestyles.
Louise McCullough is an American neurologsit who is the Prof. Roy M. &Phyllis Gough Huffington Distinguished Chair of Neurology and is actively engaged in stroke research at the University of Texas Health Science Center in Houston,Texas. She provides neurological care at Memorial Hermann Hospital,which has a state-of-the-art stroke center and is co-director of the Mischer Neuroscience Institute.
The Vaccine Research Center (VRC),is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID),part of the National Institutes of Health (NIH),US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.
The Foundation for the National Institutes of Health (FNIH) is a not-for-profit,501(c)(3) charitable organization established by the US Congress in 1990. Located in North Bethesda,MD,the FNIH raises private-sector funds,and creates and manages alliances with public and private institutions in support of the mission of the National Institutes of Health (NIH).
Patricia A. Grady is an American neuroscientist internationally recognized for her research on stroke,which specializes in cerebral blood flow,metabolism,and function. She is director of the National Institute of Nursing Research (NINR),part of the National Institutes of Health (NIH) in Bethesda,Maryland. Grady was elected to the Institute of Medicine in 1999 and is a member of several scientific organizations,including the Society for Neuroscience and the American Academy of Nursing. She is a fellow of the American Stroke Association and the American Neurological Association.
Marguerite T. Littleton Kearney is an American nurse scientist. She is the director of the National Institute of Nursing Research's Division of Extramural Science Programs. Littleton Kearney was the associate dean for research at the Uniformed Services University of the Health Sciences Graduate School of Nursing.
Emily J. Erbelding is an American physician-scientist. She is the director of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID). Erbelding was previously deputy director of the Division of AIDS at NIAID. She was a faculty member at Johns Hopkins School of Medicine and served as director of clinical services for the Baltimore City Health Department STD/HIV program.
Hugh Auchincloss,Jr.,is an American immunologist and physician serving as the acting director of the National Institute of Allergy and Infectious Diseases since 2023. He previously served as the principal deputy director between 2006 and 2022. He was previously a transplant surgeon and professor of surgery at Harvard Medical School,and researched at Massachusetts General Hospital for 17 years.
Jill Reiss Harper is an American molecular biologist and policy advisor serving as the deputy director for science management and executive officer at the National Institute of Allergy and Infectious Diseases.
Lawrence A. Tabak is an American dentist and biomedical scientist serving as the principal deputy director of the National Institutes of Health. He served as acting director from 2021 to 2023. Previously he was the director of the National Institute of Dental and Craniofacial Research from 2000 to 2010.
Shannon Nicole Zenk is an American nurse scientist specialized in researching social inequities and health disparities. She is director of the National Institute of Nursing Research.
John R. Mascola is an American physician-scientist,immunologist and infectious disease specialist. He was the director of the Vaccine Research Center (VRC),part of the National Institute of Allergy and Infectious Diseases (NIAID),National Institutes of Health (NIH). He also served as a principal advisor to Anthony Fauci,director of NIAID,on vaccines and biomedical research affairs. Mascola is the current Chief Scientific Officer for ModeX Therapeutics.
Christine M. Hunter is an American clinical psychologist and a uniformed service officer. She is the acting National Institutes of Health (NIH) associate director for behavioral and social sciences research and acting director of the NIH Office of Behavioral and Social Sciences Research. Hunter was an active duty officer in the U.S. Air Force from 1996 to 2006. She is a captain in the U.S. Public Health Service Commissioned Corps.
The Advanced Research Projects Agency for Health (ARPA-H) is an independent entity within the National Institutes of Health. Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms,capabilities,resources,and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that cannot readily be accomplished through traditional research or commercial activity."
Adam H. Russell is an American anthropologist who served as the acting deputy director of the Advanced Research Projects Agency for Health in 2022. He is the chief scientist of the Applied Research Laboratory for Intelligence and Security at the University of Maryland.
Jessica M. Gill is an American nurse scientist working as a Bloomberg Distinguished Professor of Trauma Recovery Biomarkers in the department of neurology at the Johns Hopkins School of Nursing and School of Medicine since 2021. She was the acting deputy director of the National Institute of Nursing Research from 2019 to 2020 and deputy director of the Center for Neuroscience and Regenerative Medicine at the Uniformed Services University of the Health Sciences until 2021.
Ann King Cashion is an American nurse scientist specialized in genetic markers that predict clinical outcomes. She is a professor emerita in the department of health promotion/disease prevention at the University of Tennessee Health Science Center. Cashion was the acting director of the National Institute of Nursing Research from 2018 to 2019.
{{cite journal}}
: Cite journal requires |journal=
(help)